COVID‐19 vaccine response → HM<solid
Breakthrough infections → HM>solid
Vaccine effectiveness → Population studies urgently needed
Early #COVID19CP could be lifesaving in immunocompromised HM pts
This article is protected by copyright. All rights reserved
Keywords: SARS-CoV-2; blood cancer; breakthrough infections; leukemia; lymphoma; vaccine effectiveness.